The goal of the XC project is to create a line of osteogenic products that can be used to treat a variety of orthopedic conditions.
Osiris Therapeutics is a stem cell therapeutic company focused on developing products to treat serious medical conditions in the inflammatory, orthopedic and cardiovascular areas.
